SPS Spotlight Monthly Digest June 2022 - Resources to support healthcare professionals working in all areas of the health system * Please share ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
SPS Spotlight Monthly Digest June 2022 Resources to support healthcare professionals working in all areas of the health system * Please share with the wider team * The first stop for professional medicines advice www.sps.nhs.uk www.sps.nhs.uk
SPS TRANSFORMATION SPS Transformation The SPS Transformation Programme pause has been lifted by NHS England and NHS Improvement. The matters which arose in March 2022 have been resolved and the process can now continue on a firm footing. We are now working towards an implementation date of 1st September 2022 Learn more • Transforming the Specialist Pharmacy Service • Specification for the Specialist Pharmacy Service www.sps.nhs.uk 23/06/2022 2
HOT TOPICS Ranibizumab biosimilar – information to support implementation will be available from our website by the beginning of July 2022. www.sps.nhs.uk 23/06/2022 3
RECOMMENDED IN PRIMARY CARE Swallowing difficulties - All our advice on using medicines safely and effectively in patients with swallowing difficulties. • Parkinson's disease medicines formulations for adults with swallowing difficulties Safety in breastfeeding - All our training and guidance to help decision making about the use of medicines in breastfeeding. • Using Chloramphenicol in breast feeding Safety in pregnancy - All our training and guidance to help decision making about the use of medicines in pregnancy. Medicines monitoring - Summarised recommendations and guidance for medicines requiring monitoring to save time when making monitoring decisions with patients. www.sps.nhs.uk 23/06/2022 4
ADVICE & GUIDANCE The COVID-19 Specialty Summaries pages have been retired, removed from the website and archived on the 10th June 2022. Using smallpox vaccine for monkeypox exposure - Considerations for giving smallpox vaccine pre or post exposure during a monkeypox incident. Use of individually named medicines in HM Prisons - Advice on the use of individually named patient supplies versus stock medication for residential custodial settings. Medication Safety Evidence Summaries (May 2022) - An observatory of the latest medicines safety information including national patient safety alerts, MHRA Drug Safety updates and more. www.sps.nhs.uk 23/06/2022 5
GOVERNANCE & REGULATORY How to develop a Patient Group Direction - A step by step guide to help organisations and individuals navigate all stages of the PGD development process. PGD Learning resources: Did you miss our recent webinar series? You can find it here Looking for an e-Learning programme on PGDs to support the development of all healthcare professionals? SPS have worked in partnership with HEE and UKHSA, to support all professionals involved in the development, approval, review and use of PGDs across all healthcare sectors. Access the PGD eLearning programme here. www.sps.nhs.uk 23/06/2022 6
PGD ENQUIRY ANSWERING SURVEY RESULTS 2022: WHAT DID YOU SAY? www.sps.nhs.uk 6/23/2022 7
WEBINARS & EVENTS In case you missed it: Find our events programme and recordings from past events here: SPS offer regular learning and networking opportunities which are either webinars, conferences, delivered online or in person. NEXT Events: We are taking a summer recess from our events offer and will resume our regular webinars and conferences in September. Details will be provided in the next SPS Spotlight Monthly Digest. www.sps.nhs.uk 23/06/2022 8
PLANNING New Medicines News - Highlights recent new product launches and regulatory changes. New Product Evaluations - Lists new product evaluations freely available to NHS staff. New Medicines Supply Tool - Information provided by DHSC and NHSEI Medicines Supply Teams for medication shortages (you must be registered and signed into our website to access this resource). www.sps.nhs.uk 23/06/2022 9
SUPPLY Remifentanil: shortage of all strengths, allocation of approximately 50% of historical use. Trusts have been informed of this allocation. Stock will be centralised for ease of ordering and monitoring. MSN has been issued. Contrast Media: shortage of GE contrast media Omnipaque and Visapaque. The manufacturer is now working at 100%, but is concentrating on 4 lines, MSN has been issued. If there are specific issues, please contact your RPPS and they can escalate to CMU and DHSC. Calcium folinate injection: There are a number of products from 3 suppliers that are subject to periodic out of stock issues. Vincristine sulphate: shortage of 1mg/1ml and 2mg/2ml solution for injection vials. MSN has been issued. See medicines supply tool for more information. www.sps.nhs.uk 23/06/2022 10
SUPPLY Commercial compounders: SPS colleagues continue to work with NHSE&I infusions and Special Medicines Board on recovery plans with aseptic compounders and have developed a slide set of core messages for Trusts (see next slide). It's essential that Trusts continue to implement these measures. Aseptic compounding services continue to struggle to meet demand in response to the severe disruption of supply from two non-NHS service providers. Performance has again deteriorated due to COVID absence and weekly meetings with one supplier have been reinstated. SPS has been asked to support Regional Chief Pharmacists in establishing oversight groups. DHSC Medicines Supply Team is now maintaining a strategic overview. SPS is also working with DHSC and CMU and with compounders and Homecare providers to formalise systems for the management of shortages and considering how to develop a management process for service failures in these areas. Use of licensed ready to administer chemotherapy products is one of the key recommendations. The existing irinotecan and gemcitabine range is being extended in Autumn 2022, along with the introduction of licensed pemetrexed bags. Trusts should plan for a rapid introduction of these products. www.sps.nhs.uk 23/06/2022 11
Supply of aseptically compounded medicines: key messages NHS Trusts need to support NHSEI-led NHSEI will continue to work on the strategic supplier management by: following areas with suppliers by: Ensuring and sustaining NHS-wide awareness and Encouraging collaborative working within the NHS understanding of the supply challenge and between NHS and suppliers Maximising use of system/regional procurement Facilitating sharing of data contracts Universal use of EDI for ordering of aseptic products Prioritising supply of compounded ready-to- where possible administer cytotoxic chemotherapy and PN Maximising use of standing orders Minimising accumulation of back orders Maximising use of national dose bands Supporting development of “supply-from-stock” models Maximising use of licensed ready-to-administer Maximising use of system/regional procurement products contracts Minimising outsourcing of patient-specific doses Minimising off-contract procurement www.sps.nhs.uk 23/06/2022 12
AND FINALLY.....REMEMBER.. CLICK HERE FOR OUR HOME PAGE: WWW.SPS.NHS.UK BOOKMARK THE SPS WEBSITE AND REGISTER HERE –MAKE SURE YOU 'OPT IN' TO HEAR FROM US Feedback to SPS VERY welcome. Why not let your Regional SPS representative know ONE thing that we can do to improve our service. You can save the Slide deck if helpful for accessing links. Keeping up to date: Look out for the weekly SPS bulletin. You must be logged in. Then check drop down box for email updates. Follow SPS on Twitter @NHS_SPS www.sps.nhs.uk 23/06/2022 13
You can also read